STATE STREET CORP, a registered investment adviser, initiated a new position in Boston Scientific Corporation (NYSE:BSX) during Q4 2025, according to its most recent 13F filing…
STATE STREET CORP, a registered investment adviser, initiated a new position in Boston Scientific Corporation (NYSE:BSX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 65,846,059 shares of the Healthcare company, valued at approximately $6.3B as of the filing date.
Boston Scientific Corporation's stock currently trades at $76.07 with a market capitalization of $136.0B.
Current market data
NYSE · BSX
$48.37
Up: +$0.29 · +0.59%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
insider ·
insider ·
institutional ·
sec_filing ·
